TISSARA Trial: Ticagrelor Intervention to Reduce Stent Thrombosis and Acute MI Risk
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1727 participants.
Also called NCT06667349
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 1,727 participants
- Registry
-
NCT06667349
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Pakistan
- Registry status
- Completed
Technical summary
Registry record NCT06667349. Non-randomized; no masking; primary purpose prevention. Start 2023-08-24 (actual); primary completion 2024-03-03 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- TISSARA Trial: Ticagrelor Intervention to Reduce Stent Thrombosis and Acute MI Risk
- Acronym
- TISSARA
- Condition
- STEMI - ST Elevation Myocardial Infarction
- Condition
- Stent Thrombosis
- Condition
- Antiplatelet Agents
- Intervention (Drug)
- Ticagrelor
- Lead sponsor
- National Institute of Cardiovascular Diseases, Pakistan
Record details
- Record id
cardio:ct-nct06667349- Content hash
8be4951632722381f904f2072a7fca64b13395eb8a7ca45bd2e777a1575a6c61